IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $0.54, $0.26 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $352 million versus the consensus estimate of $373.2 million.

IDEXX Labs sees FY2015 EPS of $4.33 - $4.43, versus the consensus of $4.39. The company also sees 13.5 - 14.5 percent normalized organic revenue growth, an increase from prior views.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.